DAMARIS CARRIERO: Open Payments
NPI 1831269794 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 14 payments from 3 companies in 2025. Trend: 2023 $5,828 · 2024 $1,702 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 8 | $305 |
| Madrigal Pharmaceuticals | 5 | $227 |
| Intra-Sana Laboratories | 1 | $21 |
Products named: REZDIFFRA, RELTONE 200 MG.
Industry payments across NY — which companies pay providers there.
